Pharmaceutical foams with optimized microemulsion

June 30, 2016

Discover the latest poster on pharmaceutical foams presented at PBP Glasgow 2016: "Pharmaceutical foams with optimized microemulsion and propellant-free pump". Live version as if you were at the exhibition.

Spotlight

Porton Biopharma Ltd

Porton Biopharma Limited (PBL) is a UK based company experienced in developing, manufacturing and bringing to market biopharmaceutical therapeutics and vaccines. PBL was corporatised out of Public Health England on 1st April 2015 to enable us to be better placed to grow our business, which is built upon decades of biopharmaceutical experience including the successful commercialisation and licensure of many therapies which now save thousands of lives every year, and generate revenues from world-wide sales.

OTHER VIDEOS

Welcome to the Azelis Pharma lab in Paris, France!

video | January 30, 2023

As a leading global innovation service provider in the specialty chemicals and food ingredients industry, we are committed to creating value for principals and customers whilst providing a great work environment and career opportunities....

Watch Now

Daikyo Crystal Zenith® Insert Needle Syringe

video | January 27, 2023

The Daikyo Crystal Zenith® Insert Needle Syringe system was designed to maintain purity, integrity and efficacy of premium biopharmaceutical therapies....

Watch Now

Little Green Pharma continues to expand making significant strides

video | January 31, 2023

Leading Australian medicinal cannabis exporter, Little Green Pharma continues to expand making significant strides in lucrative global markets...

Watch Now

Teva Expands Partnership to Bring Critical Medicines to Children Living with Cancer

video | January 26, 2023

Teva believes medicine should always be accessible, and we work to help make this a reality. We're working with Global HOPE (Hematology Oncology Pediatric Excellence), a non-profit...

Watch Now

Spotlight

Porton Biopharma Ltd

Porton Biopharma Limited (PBL) is a UK based company experienced in developing, manufacturing and bringing to market biopharmaceutical therapeutics and vaccines. PBL was corporatised out of Public Health England on 1st April 2015 to enable us to be better placed to grow our business, which is built upon decades of biopharmaceutical experience including the successful commercialisation and licensure of many therapies which now save thousands of lives every year, and generate revenues from world-wide sales.

Events